Ken Yamazumi
Direktor/Vorstandsmitglied bei SanBio, Inc.
Aktive Positionen von Ken Yamazumi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Comptroller/Controller/Auditor | - | - |
| Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Ken Yamazumi
Ehemalige bekannte Positionen von Ken Yamazumi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KYOWA KIRIN CO. LTD. | Direktor/Vorstandsmitglied | 05.01.2010 | 22.03.2012 |
| Corporate Officer/Principal | 05.01.2010 | 22.03.2012 | |
Kirin Pharma Co. Ltd.
 Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Vorsitzender | 01.07.2007 | 06.10.2008 |
| Präsident | 01.07.2007 | 06.10.2008 |
Ausbildung von Ken Yamazumi
| University of Tokyo | Undergraduate Degree |
Statistik
International
| Japan | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 2 |
| Chairman | 1 |
| President | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Kirin Pharma Co. Ltd.
Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
- Börse
- Insiders
- Ken Yamazumi
- Erfahrung
